An international health insurance policy can be well designed, generously funded and thoroughly useless for the purpose you bought it. The reason is rarely the benefit schedule. It is that insurance regulation attaches to the place where the insured risk is located, not to the place where the contract was signed or the premium was paid, and a policy written from outside that place occupies a different legal position from one written inside it.
That difference is the admitted versus non-admitted distinction, and it sits underneath almost every practical question an internationally mobile person asks about health cover: whether a policy will get a residence permit issued, whether an employer's obligation has been discharged, whether a tax has been triggered, and who will listen if a claim is refused. It is also the axis on which no comparison site competes. Plans are compared on limits, areas of cover and modules, all of which are visible in a brochure. Admitted status is not visible in a brochure at all.
This guide explains what the distinction is, the three consequences that follow from it, and the structure the market uses to work around it.
What makes a policy admitted
A policy is admitted when the entity carrying the risk holds a licence to conduct insurance business in the country where the risk sits — in health insurance, generally the country where the insured person lives. Non-admitted describes the opposite case: an insurer licensed in one jurisdiction writing a risk located in another, without local authorisation.
Two clarifications matter before going further.
First, admitted status is a fact about the risk carrier, not about the brand. In international medical insurance the name on the certificate is frequently an intermediary, an administrator or a managing general agent rather than the insurer. Establishing admitted status therefore begins by working out who actually underwrites the policy, which is the subject of who carries the risk: underwriters, MGAs and fronting.
Second, some markets add a second gate. A general insurance licence may not be enough; a separate health-specific authorisation from the health regulator may also be required, so an insurer can be licensed in a country and still not be permitted to write the compulsory health product there. Where that structure exists, the operative test is whether the insurer appears on the regulator's published list.
Consequence one: whether the policy satisfies a legal mandate
The sharpest consequence is compliance. Where a jurisdiction makes health cover compulsory, it almost always specifies who may write it, and the specification is usually expressed as a licensing requirement rather than a benefit requirement.
Germany states this more plainly than anywhere else. §193(3) VVG requires a resident to hold health insurance with an insurance undertaking licensed to do business in Germany. The benefit test that follows — reimbursement of outpatient and inpatient treatment, with any self-retention capped — is secondary to the licensing test that precedes it. §146 VAG then confines substitutive health insurance to business conducted domestically on life-insurance principles, with ageing reserves and no ordinary right of termination. A cross-border annually renewable contract does not have that shape.
The Gulf states are the other clear case. Practitioner commentary from insurance law firms describes the UAE as prohibiting non-admitted insurers from writing locally situated risks including health, and describes substantially similar prohibitions across the other GCC states. That is commentary rather than regulation, and it should be read as such — but it is consistent, and it is corroborated by what the individual regimes require. Where a regulator maintains a register of permitted insurers and requires enrolment through a listed carrier, an offshore policy cannot satisfy the rule however good it is.
Nothing here should be read as a view on whether any particular policy meets any particular mandate. That is a question about a named insurer, a named country and a current register, and it changes. What this guide can do is tell you which test to apply. The country guides — UAE, Saudi Arabia, Qatar and Kuwait and Germany — set out the shape of each regime.
Consequence two: where the premium tax obligation lands
The second consequence is fiscal and easy to miss because it never appears on the renewal notice.
Most jurisdictions levy some form of tax or parafiscal charge on insurance premiums. Where the insurer is locally licensed, that insurer normally registers, collects and remits the tax, and the customer experiences it only as part of the price. Where cover is written from outside the jurisdiction, a number of regimes place the registration, filing and payment obligation on the policyholder instead, on the reasoning that the state cannot practically pursue an entity it does not license.
The result is an obligation that can attach to an individual or an employer without ever being flagged by the insurer, because the insurer is not the one who owes it. Rates, thresholds and the treatment of health cover specifically vary enormously and are not worth generalising. The structural point is worth knowing: an unadmitted premium is not automatically a tax-free premium. Insurance premium tax on medical cover deals with the mechanics.
Consequence three: your regulator, and your complaints route
The third consequence is the one people discover at the worst moment. Admitted status determines which supervisory system your policy sits inside, and therefore which conduct rules apply, which complaints body will accept your case, and whether any local policyholder protection arrangement is available if the carrier fails.
A worked example makes the point concrete. Under one international policy currently in the market, the plan is arranged and administered by a Belgian-registered entity whose UK branch is FCA-authorised, while the risk is underwritten by a French insurer regulated by the ACPR. The policy documentation directs UK-based members to the Financial Ombudsman Service and non-UK members to the French insurance mediation service, and splits the data protection route the same way, between the UK Information Commissioner's Office and the Belgian data protection authority. Nothing about that is irregular. But a member living in, say, Malaysia is being pointed to a French mediator over a policy sold by a Belgian entity through a UK branch, and none of those bodies sit in the country where the treatment took place.
That is the real content of "which regulator do I have". It is not an abstraction; it is a list of addresses, and it is worth reading before you need it. Insurer solvency ratings and due diligence sets out the questions to ask.
Fronting: the standard workaround, and where it narrows
The market's answer to admitted-only markets is fronting. A locally licensed insurer issues the policy — so the contract is admitted, satisfies the local rule and appears on the regulator's register — and then cedes most or all of the underlying risk to an international reinsurer under a reinsurance treaty. The customer's contract is with the local carrier. The economics sit offshore.
Fronting works because most jurisdictions regulate direct insurance far more tightly than reinsurance. Sources describing the UAE market note that foreign reinsurance of UAE risks is not restricted in the same way, which leaves the fronting route open. Saudi Arabia restricts foreign reinsurance as well, which narrows the route there materially and is one reason the Saudi regime is generally described as the strictest of the group.
The visible symptom of fronting is a per-territory underwriter list. Now Health International, for example, publishes different underwriting entities for different regions, with regulators including the DFSA, the Malta Financial Services Authority and the FCA appearing across the range. An international plan that names one insurer in Singapore, another in Hong Kong and another in the UAE is not being inconsistent. It is being admitted.
What restriction looks like from the customer's side
Because licensing is invisible to buyers, it shows up in product design in ways that look arbitrary until you know what you are seeing.
| What you see | What it usually means |
|---|---|
| A "worldwide" plan that excludes specific wealthy countries | The insurer has no authorisation to write risks located there |
| An application refused on grounds of your country of residence | Residence determines where the risk sits, so residence determines licensing |
| A different underwriter named for each territory | Fronting, or a genuine multi-entity licensed structure |
| A separate locally issued policy sold alongside the international plan | The local policy carries the mandate; the international plan carries the rest |
Two published examples make this tangible. VUMI's own site returns, for certain locations, a message that it is unable to provide cover to individuals, corporations and expatriates holding permanent residency in that location — a geographic restriction expressed in terms of residency status, which is the language of licensing rather than underwriting. Morgan Price's Evolution Health international product excludes the UK and the UAE from its area of cover, alongside a handful of sanctioned markets; both of those exclusions sit next to separately arranged local propositions in the same markets.
The practical reading is that "international" has never meant "everywhere", and the gaps are frequently regulatory rather than commercial. IPMI versus local health insurance abroad covers the choice this forces.
Working out where your own policy stands
Four questions, in order:
- Who carries the risk? Read the policy wording and the product information document, not the marketing page. Identify the underwriter and the regulator named for it.
- Where is the risk situated? For health cover this is normally your country of residence, which is why insurers require immediate notification of a change of residence.
- Is that underwriter licensed there? Check the register maintained by the insurance regulator in that country.
- Is there a second gate? In markets with a compulsory scheme, check whether the health regulator maintains its own list of permitted or participating insurers, and whether the underwriter is on it.
If the answer to (3) or (4) is no, the policy is not thereby worthless. It may still be excellent supplementary cover sitting on top of a compliant local base policy, which is the ordinary structure across the Gulf. What it cannot do is discharge an obligation that the law has framed in licensing terms. The sequencing problem this creates is the subject of visa-stage versus residence-stage health cover, and the specific documentary tests are collected in health insurance requirements for visas.
These rules change, and you must check them
Mandatory health insurance regimes and insurance licensing rules change frequently, and they have changed repeatedly in the Gulf in particular over the last few years. The positions described here reflect research current as at July 2026, drawn from regulator publications, statutory texts and professional commentary. They are not a substitute for a current check.
Before you rely on any of it, confirm the position with the insurance or health regulator in the country concerned, with your employer or sponsor if they are the party carrying the legal duty, and with the insurer itself in writing. Where an official source and a broker source disagree, the official source is the one to follow — and where two official sources disagree, which does happen, the honest answer is that the position is unsettled and you should ask.
Frequently asked questions
What does "admitted insurance" actually mean?
An admitted policy is one written by an insurer that holds a licence to conduct insurance business in the country where the insured risk is located — usually the country where you live. Non-admitted means the insurer is licensed somewhere else and is writing the risk across a border. The distinction has nothing to do with the quality of the cover or the size of the insurer. It is purely a question of which regulator authorised the entity that carries the risk, and where.
Is non-admitted insurance illegal?
It depends entirely on the jurisdiction. Some countries permit cross-border insurance freely, some permit it only for risks that cannot be placed locally, and some prohibit it outright. Practitioner commentary describes the Gulf states as prohibiting non-admitted insurance for locally situated risks, health cover included. Because the prohibition usually bites on the insurer rather than the customer, the practical consequence for a policyholder is more often an unenforceable contract or a failed compliance check than a personal penalty.
What is fronting in insurance?
Fronting is the standard structure used to place international risk in a market that requires local licensing. A locally licensed insurer issues the policy, so the contract is admitted and satisfies the local rule, and then cedes most or all of the risk to an international reinsurer under a reinsurance treaty. The customer deals with the local paper; the economic risk sits offshore. The route depends on the jurisdiction permitting foreign reinsurance, which not every market does.
Does an admitted policy pay claims any differently?
Not as a matter of contract. Admitted status changes the legal and regulatory position around the policy rather than the benefit schedule inside it. What it does change is your recourse if something goes wrong: an admitted policy is supervised by the regulator in your own country, so complaints, conduct rules and any local policyholder protection arrangements are reachable. With a non-admitted policy, all of that sits wherever the insurer is licensed.
Who pays insurance premium tax on a non-admitted policy?
In several jurisdictions the obligation shifts. Where an insurer is locally licensed it normally collects and remits any premium tax itself, so the customer never sees it as a separate step. Where cover is written from outside, some regimes place the filing and payment obligation on the policyholder instead. The point is not the rate, which varies widely, but the fact that a duty can attach to you personally without appearing anywhere on the invoice.
How do I find out whether my own policy is admitted where I live?
Start by identifying the entity that carries the risk, which is often not the brand on the certificate. The policy wording and product information document will name the underwriter and its regulator. Then check whether that entity appears on the register maintained by the insurance regulator in your country of residence, and whether any separate health-specific authorisation is also required. Where the regulator publishes a list of approved insurers, appearing on it is the test.
Why do some insurers refuse to sell to residents of particular countries?
Geographic exclusions in international policies are frequently licensing decisions rather than underwriting ones. If an insurer has no authorisation in a market, it cannot lawfully write a risk situated there, so it either declines applications from residents of that country or excludes the territory from its area of cover. That is why you sometimes find wealthy, well-served markets carved out of an otherwise worldwide plan.
This guide is general information only and does not constitute financial, legal, medical or tax advice. Global Investments is not authorised by the Financial Conduct Authority. Insurance products, benefit schedules and premiums are revised regularly, and mandatory health insurance requirements change frequently — in several jurisdictions they are described differently even between official sources. Nothing here is a recommendation of any product or insurer. Confirm the legal position with the relevant regulator or a locally qualified adviser, and confirm cover terms with the insurer, before acting.